Ferrous fumarate 322mg tablets

Nchi: Uingereza

Lugha: Kiingereza

Chanzo: MHRA (Medicines & Healthcare Products Regulatory Agency)

Viambatanisho vya kazi:

Ferrous fumarate

Inapatikana kutoka:

Advanz Pharma

ATC kanuni:

B03AA02

INN (Jina la Kimataifa):

Ferrous fumarate

Kipimo:

322mg

Dawa fomu:

Oral tablet

Njia ya uendeshaji:

Oral

Darasa:

No Controlled Drug Status

Dawa ya aina:

Valid as a prescribable product

Bidhaa muhtasari:

BNF: 09010101; GTIN: 5021691032243

Taarifa za kipeperushi

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
FERROUS FUMARATE 322MG
FILM-COATED TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs
of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed in
this leaflet. See section 4.
The name of your medicine is Ferrous Fumarate 322mg Film-Coated
Tablets. It will be referred to as Ferrous
Fumarate Tablets for ease hereafter.
WHAT IS IN THIS LEAFLET
1. What Ferrous Fumarate Tablets are and what they are used for
2. What you need to know before you take Ferrous Fumarate Tablets
3. How to take Ferrous Fumarate Tablets
4. Possible side effects
5. How to store Ferrous Fumarate Tablets
6. Contents of the pack and other information
1. WHAT FERROUS FUMARATE TABLETS ARE AND WHAT THEY ARE USED FOR
Ferrous Fumarate Tablets contain a form of iron called ferrous
fumarate. Iron is usually found in foods and is
necessary for the normal development of red blood cells. A lack of
iron affects the development of the red blood cells
and causes iron deficiency anaemia.
Ferrous Fumarate Tablets are used to prevent or treat iron deficiency
anaemia.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE FERROUS FUMARATE TABLETS
DO NOT TAKE FERROUS FUMARATE TABLETS IF
• You are allergic to Ferrous fumarate or any of the other
ingredients of this medicine (listed in section 6), or to any
other medicine containing iron
• You have noticed blood in your urine
• You suffer from any form of anaemia, other than iron deficiency
anaemia, or from any other condition where your
body’s iron is affected (your doctor will be able to advise you)
• You have bronze markings on your skin or you have been told that
you

Tabia za bidhaa

OBJECT 1
FERROUS FUMARATE 322MG TABLETS
Summary of Product Characteristics Updated 10-Oct-2019 | ADVANZ Pharma
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Fersaday 322mg Tablets
Ferrous Fumarate 322mg Film-Coated Tablets
2. Qualitative and quantitative composition
Each tablet contains 322.0mg Ferrous Fumarate BP (equivalent to
approximately 100 mg ferrous iron)
For the full list of excipients, see section 6.1
3. Pharmaceutical form
Film-coated Tablets
Each film coated tablet is brown ochre in colour and engraved 'FE' on
one face and '322' on the other.
4. Clinical particulars
4.1 Therapeutic indications
Prophylaxis and treatment of iron deficiency states.
4.2 Posology and method of administration
Posology
Adults and the elderly: One tablet daily (the foil enclosing the
tablet is printed with days of the week in
sequence).
In severe or refractory iron deficiency, one tablet may be given twice
a day.
_Paediatric population:_ Ferrous Fumarate tablets are not intended fo